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term linezolid treatment.
Methods: A retrospective analysis was conducted to calculate the cumula-
tive amount of linezolid administered to an elderly patient with pneumonia
during prolonged therapy with linezolid. Three sequential isolates were
identified, its minimum inhibitory concentration (MIC), homology and drug
resistant related genes (cfr, 23S rRNA) were investigated.
Results: One linezolid-resistant strain of methicillin-resistant Staphylo-
coccus aureus (MRSA) was isolated from sputum of the patient at Xijing Hos-
pital. The MIC of linezolid had increased from 1.5 mg/ml of initial strain 083
in March 2012 to subsequent 4.0 mg/ml of strain 158 in November 2012 and
16.0 mg/ml of strain 231 in March 2013 respectively. The increasing MIC
values to linezolid were directly correlated with the cumulative amount of
linezolid 118.8 g administered over 99 days. Strain 158 had heterogeneous
resistance to linezolid. Molecular typing showed that three MRSA strains
belonged to MLST ST-239 (spa t-030) with 98.8% homology. Cfr mutation
was not detected but 23S rRNA mutation G2603T was confirmed in strains
158 and 231.
Conclusions: This is the first case of linezolid-resistant MRSA isolated in
China. The long-term use of linezolid for the treatment of MRSA infection
was associated with a 23S rRNA G2603T mutation, which mediates heteroge-
neous resistance to linezolid. And the strain with heterogeneous resistance
might progress to a high-level linezolid-resistant strain when re-exposed to
linezolid.
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CORRELATION OF MOLECULAR TYPES WITH ANTIMICROBIAL
SUSCEPTIBILITY PROFILES AMONG 670 MECA-POSITIVE MRSA ISOLATES
FROM STERILE SITES (TIST STUDY, 2006-2010)
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1Feng-Yuan Hospital, Taichung, Taiwan; 2Central Taiwan University of
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Background: Methicillin-resistant Staphylococcus aureus (MRSA) is the
most frequent organism that causes severe healthcare- and community-
associated infections. Association of molecular types and antimicrobial
susceptibility test (AST) profiles has been reported. The goal is to corre-
late various molecular types with AST profiles of MRSA isolates from
Taiwan.
Materials and Methods: MRSA from sterile sites were collected during 5
years from 22 hospitals (Tigecycline In-vitro Surveillance in Taiwan e
TIST 2006e2010) and AST including seventeen antibiotic regimens and
inducible macrolide-lincosamide- streptogramin B (MLSBi) phenotype
were determined by Vitek-II automated system. Molecular types including
SCCmec, spa, and dru were determined by PCR and nucleotide
sequencing. Multidrug resistance (MDR) was defined an isolate with resis-
tance to more than or equal to three non-b-lactam antibiotics. Correlation
with molecular types with antibiotic resistance was determined by
Fisher’s exact test.
Results: Totally 670 mecA+ MRSA were collected, among which most were
from blood (627, 93.6%). The susceptibility rates determined by Vitek-II
were as followed: linezolid and teicoplanin (100%), vancomycin (99.9%),
tigecycline (99.7%), daptomycin (95.1%), fusidic acid (85.5%), rifampicin
(68.7%), trimethoprim (53.7%), moxifloxacin (36%), tetracycline (34.2%),
and less than 10% for cefoxitin, cefazolin, penicillin, oxacillin, erythro-
mycin, clindamycin, and ampicillin/sulbactam. MRSA with MDR (542,
80.9%) was associated with molecularly HA-MRSA (e.g., SCCmecII&III;
spa t002&t037; agr group II; dru4, 12, and 14). (p from < 0.001 to <
0.01). MLSBi (57, 8.5%) correlated with molecular types of SCCmecIII&V,
spa t3525, and agr group III (p < 0.01). The compound annual growth
rate of susceptibility from 2006 to 2010 ranged from -2% of fusidic acid
to 13% of clindamycin and 17% of erythromycin, respectively.
Conclusions: MRSA from Taiwan had varied AST profiles and some with
increasing susceptibility within 5 years. Strains with particular molecularphenotypes had corresponding AST profiles that were distinct from those
of endemic MRSA clones reported.
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DISTRIBUTION AND DRUG RESISTANCE OF PATHOGENS CULTURED FROM
63229 BLOOD SPECIMENS
Linhan Feng, Xiuli Xu, Xin Fan, Jiayun Liu. Department of Clinical
Laboratory, Xijing Hospital, Fourth Military Medical University, Xi’an
710032, China
Purpose: Dynamic Monitoring and Analysis in our hospital from 2007 to 2013
clinical testing of blood culture samples isolated pathogen distribution and
drug resistance changes, the rational use of antimicrobial drugs for clinical
laboratory evidence.
Methods: Using BACTEC automated blood culture system on 63,229 blood
specimens for testing; application of automatic identification of bacteria
bacterial identification analyzer identified to species; bacterial susceptibil-
ity testing by KB method, according to the American Society for Clinical Lab-
oratory Standards Institute requirements standards; pathogen distribution
and antimicrobial susceptibility test results apply WHONET5.6 software for
statistical analysis.
Results: From a clinical inspection of 63,229 blood specimens, the positive
culture 4914, the positive rate of 7.77%, were detected pathogens 2196,
which accounted for 46.08 Enterobacteriaceae (1012/2196), nonfermenters
13.93 (306/2196) ; Staphylococcus 13.70 (301/2196), Enterococcus 8.24
(181/2196); mainly Gram-negative bacteria Escherichia coli, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, The
detection rates were 25.50%, 11.47%, 7.14%, 5.91%. Gram-positive bacteria
to coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus,
grass green hammer main separation rates were 10.40%, 7.42%,
6.87,3.91%. Fungal 7.05 (155/2196), the separation rate of the first two of
Candida albicans and Candida tropicalis, the detection rates were 2.18%,
2.00%; brucellosis 1.01 (32/2196), pollution bacteria 4.01 (88/2196), produc-
ing ESBLs of Escherichia coli and Klebsiella pneumoniae separation rates
were 75.53%, 55.51%; methicillin-resistant Staphylococcus aureus (MRSA)
isolation rate was 62.6%, not seized the resistance to vancomycin, line-
zolid-resistant Staphylococcus aureus.
Conclusions: Bloodstream infection pathogen distribution as Escherichia
coli, Klebsiella pneumoniae, coagulase-negative staphylococci, Staphylo-
coccus aureus, Enterococcus, Acinetobacter baumannii, Pseudomonas aeru-
ginosa. Clinical blood culture specimens should be strictly in accordance
with the norms adopted send execution to avoid pollution and improve the
quality inspection.
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Background: Infections with carbapenem-resistant Klebsiella pneumoniae
(CRKP) are emerging causes of morbidity and mortality at institutions world-
wide. In addition, the efficacy of cefepime for such infections is
controversial.
Methods: A retrospective study of monomicrobial bloodstream infections
(BSIs) caused by Klebsiella pneumoniae resistant to one of ertapenem, imi-
penem or meropenem, at a medical center between 2008 and 2013, was con-
ducted. The 30-day crude mortality was the primary end point.
S40 Abstracts of the 7th International Congress of the Asia Pacific Society of Infection Control, Taipei, Taiwan, March 26-29, 2015Results: Overall there were 126 patients with CRKB BSIs in the study period.
According to the latest minimum inhibitory concentration (MIC) interpretive
breakpoints for Enterobacteriaceae issued by the Clinical and Laboratory
Standards Institute (CLSI), 64 (50.8%) CRKP isolates were susceptible to cefe-
pime (total 126 isolates showed MIC range: 0.5-128; MIC90: 64 mg/L). Of 22
(17.5%) patients with cefepime-susceptible CRKP BSI, cefepime definitive
therapy showed a significantly lower mortality than other antibiotics (2/
22, 9.1% vs. 40/104, 38.5%, P Z 0.007). In logistic regression analysis, 30-
day mortality was independently associated with critical illness (odds ratio
[OR]: 14.6; 95% confidence interval [CI]: 4.2-50.9; P < 0.001); pneumonia
(OR: 7.3; 95% CI: 1.8-30.4; P Z 0.006); a rapidly fatal underlying disease
(OR 9.5; 95% CI 1.5-58.9; P Z 0.015), and definitive cefepime therapy
(OR: 0.1; 95% CI: 0.01-0.8; P Z 0.028).
Conclusions: Cefepime may be useful for the treatment of BSIs due to car-
bapenem-resistant but cefepime-susceptible K. pneumoniae, particularly if
source control is achieved.
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CARBAPENEM-RESISTANT VERSUS CARBAPENEM-SUSCEPTIBLE
ACINETOBACTER BAUMANNII BACTEREMIA IN A TEACHING HOSPITAL IN
CHINA: RISK FACTORS AND OUTCOMES
Fu Qiao, Wenzhi Huang. Infection Control Department, West China Hospital,
S.C.U., Chengdu, China
Purpose: The objective of this study was to compare the mortality associ-
ated with Carbapenem- resistant Acinetobacter baumannii (CRAB) versus
Carbapenem-susceptible Acinetobacter baumannii (CSAB) bacteremia, and
to determine specific risk factors for CRAB isolates in a 4300-bed teaching
hospital in China.
Methods: We performed a retrospective case-control study between January
1, 2010 and December 30, 2013. One hundred and sixty three patients with
CRAB bacteremia cases were compared to sixty eight unmatched patients
with CSAB bacteremia controls during the study period.
Results: The mortality rate was 32.5% and 4.4% in CRAB and CSAB cases
respectively (PZ 0.000). The risk factors for mortality were got bacteremia
with CRAB (hazard ratio [HR], 15.55; 95% confidence interval [CI], 3.27-
74.08; P Z 0.001), hematologic malignancy (HR, 13.77; 95%CI, 4.49-42.19;
P Z 0.000), cardiovascular disease (HR, 4.53; 95%CI, 1.34-15.26; P Z
0.015) and increasing of age (HR, 1.03; 95%CI, 1.01-1.05; P Z 0.000). By
multivariate analysis, the independent risk factors for CRAB bacteremia
compared to CSAB bacteremia were emergency visit (odds ratio [OR],
2.58; 95% CI, 1.10-6.06; P Z 0.029) and ICU stay (OR, 6.64; 95%CI, 2.26-
19.54; P Z 0.001) before infection.
Conclusions: The mortality rate was much higher among patients with CRAB
bacteremia. Led to emergency and stay in ICU were found to be independent
risk factors for bacteremia with CRAB.
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Purpose: The impact of antimicrobial treatment on the outcome of carbape-
nem non-susceptible K. pneumoniae (CnsKP) infections needs to be eluci-
dated. This nationwide, multicenter study was conducted to evaluate the
impact of appropriate antimicrobial therapy on 14-day mortality among pa-
tients with CnsKP infection in Taiwan. Particular attention was focused on
the outcome related to different levels of disease severity.
Methods: Patients with CnsKP infections from 11 medical centers and four
regional hospitals in Taiwan were enrolled in 2013. Carbapenem non-suscep-
tibility was defined as a minimum inhibitory concentration of 2 mg/L forimipenem or meropenem. Predictors of 14-day mortality were determined
using the Cox proportional regression model. The influence of infection
severity on the impact of appropriate use of antimicrobials on 14-day mor-
tality was determined using the Acute Physiology and Chronic Health Evalu-
ation (APACHE) II score.
Results: Overall 14-day mortality was 31.8% (49/154 patients). Unadjusted
mortality for appropriate antimicrobial therapy was 23.1% (18/78 patients).
Appropriate therapy was independently associated with reduced mortality
(hazard ratio [HR], 0.44; 95% confidence interval [CI], 0.24 to 0.80; P Z
0.007). A subgroup analysis revealed that the benefit of appropriate therapy
was limited to patients with higher APACHE II scores (HR for patients with
scores >15 and 35, 0.46 [95% CI, 0.23 e 0.92]; HR for those with scores
>35, 0.14; 95% CI, 0.02 e 0.99).
Conclusions: In conclusion, appropriate antimicrobial therapy significantly
reduces 14-day mortality for CnsKP infections. Survival benefit is more
notable among more severely ill patients.
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EPIDEMIOLOGY AND MANAGEMENT VANCOMYCIN RESISTANT
ENTEROCOCCI AND CARBAPENEM RESISTANT ENTEROBACTERIACEAE IN
LOW RESOURCE HOSPITAL IN THAILAND
Aree Goonna, Prapaipan wongkrue, Sawalak Fupinwong, Nantana NunNgam,
Chuleewan Yamrubboon. Infection Control Unit, Chiangmai University
Hospital, Chiangmai, Thailand
Background: Hospitals in central part of Thailand has recently emerged Van-
comycin Resistant Enterococci(VRE) and Carbapenem Resistant Enterobac-
teriaceae (CRE) for 3 years ago. These organisms associated with high
mortality and high cost of treatment and care. January 2014 we found the
first case of VRE in Maharaj Nakorn Chiangmai hospital, 1400 bed facility,
a university hospital, we concerned about the spread of the organism and
cost of treatment and care.
Objectives:
1. To study epidemiology of VRE and CRE
2. To implementation infection control and prevention for new emerging
organisms in hospital.
Methods: Prospective surveillance study in all of patients visit our hospital
was done from January to June 2014. The data source for surveillance was
laboratory base system, collected using surveillance methodology and defi-
nition of Center for Disease Control. Data were analysis by using descriptive
statistics.
Implementing infection control strategies concurrent with the surveillance
data. Strategies were; set up the special policy for VRE and CRE , announce
of policy and share the guidelines. Developing manual for health care
personnel, patients and family. Support of some disposable equipment. Set
up a fast tract to notifying laboratory result report and rapid implementa-
tion, strict contact precautions . Environmental control was arranged for
proper strict isolations, in general ward we created isolation chamber with
plastic semi-hard partitions. Active surveillance of close contact patients for
2 weeks and when consequence negative clinical specimens and stool
culture. Strict contact precautions was stopped. Set up one stop service
for out patients.. For referral cases, notification system was performed to
infection control team of other hospitals.
Results: From January to June 2014, we found VRE and CRE of 27 and 25
cases consecutively. The incidence rate of VRE and CRE was 0.198/1000
and 0.184/1000 patient days, Most incident cases found in the medical
department (53.84%). For the VRE incident infected patients were 44.4 % ,
and 54.6 % were colonized patients, HAI were 44.4 % . For CRE infected pa-
tients and colonization were 52.0% and 48.0% . HAI were 40.0 %. About 33%
VRE had received Vancomycin before developed infection and colonization.
For CRE incident 56 % and 36 % had received Cephalosporin, and Carbapenem
before developed CRE. Close contact VRE patient developed colonization
22.2%, and 12.1% for CRE. Compliance of personnel, patients and relatives
were at good level. However, sometimes we encountered shortage of PPE
equipment. The major defect of practice was the thorough cleaning of envi-
ronmental surrounding surface of the patient unit which spot checked by
ATP test.
Conclusion: The incidence of VRE and CRE in Maharaj nakorn chiangmai hos-
pital is similar to incidence of hospitals those of European countries. Patient
close contact VRE index cases developed infection and colonization with VRE
